Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches
Dengue virus (DENV) is an arboviral human pathogen transmitted through mosquito bite that infects an estimated ~400 million humans (~5% of the global population) annually. To date, no specific therapeutics have been developed that can prevent or treat infections resulting from this pathogen. DENV...
Saved in:
Main Authors: | Ahammad, Foysal, Tengku Abd Rashid, Tengku Rogayah, Mohamed, Maizan, Tanbin, Suriyea, Ahmad Fuad, Fazia Adyani |
---|---|
Format: | Article |
Language: | English English English |
Published: |
MDPI AG
2019
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/79793/1/79793_Contemporary%20Strategies%20and%20Current%20Trends_article.pdf http://irep.iium.edu.my/79793/2/79793_Contemporary%20Strategies%20and%20Current%20Trends_scopus.pdf http://irep.iium.edu.my/79793/3/79793_Contemporary%20Strategies%20and%20Current%20Trends_wos.pdf http://irep.iium.edu.my/79793/ https://www.mdpi.com/2076-2607/7/9/296 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying analogues of 2-deoxyglucose, alpha-d-glucose and beta-d-glucose-6-phosphate as potential inhibitors of human hexokinase ii for the development of anti-dengue therapeutics
by: Tanbin, Suriyea, et al.
Published: (2019) -
Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system
by: Tanbin, Suriyea, et al.
Published: (2019) -
Analogues of 2-Deoxyglucose as inhibitor candidates for hexokinase II identified via virtual screening analyses
by: Tanbin, Suriyea, et al.
Published: (2018) -
Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II
by: Tanbin, Suriyea, et al.
Published: (2020) -
Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII)
by: Ahmad Fuad, Fazia Adyani, et al.
Published: (2020)